Clinical Trials Directory

Trials / Completed

CompletedNCT00100100

Modafinil for the Treatment of Cocaine Dependence - 1

Modafinil for the Treatment of Cocaine Dependence

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
210 (planned)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.

Detailed description

This is a double-blind, placebo-controlled, parallel group design study to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.

Conditions

Interventions

TypeNameDescription
DRUGModafinil

Timeline

Start date
2004-10-01
Completion
2006-12-01
First posted
2004-12-23
Last updated
2017-01-12

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00100100. Inclusion in this directory is not an endorsement.

Modafinil for the Treatment of Cocaine Dependence - 1 (NCT00100100) · Clinical Trials Directory